Medical oncologist Dr. Naomi Fujioka shares an overview of how doctors
treat BRAF-mutated lung cancer. She discusses
targeted therapies for
V600E mutated lung cancers, including the combination of trametinib and dabrafenib, and the combination of binimetinib and encorafenib.
Immunotherapy can also be a good choice for people with BRAF non-V600E mutations. Talk with your doctor about the best treatment options for your specific lung cancer and consider participating in
clinical trials.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.